Poland· PL-100129370
Wilzin
A zinc acetate product containing zincum, registered in Poland by Recordati Rare Diseases. The same ATC class is registered in 9 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Zinc acetate is registered in 9 of 19 countries.
Countries holding a registration under ATC A16AX05 (zinc acetate), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Zinc acetate · ATC A16AX05
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Zincum
- Manufacturer
- Recordati Rare Diseases
- Country
- Poland (PL)
- ATC code
- A16AX05
- ATC class
- Zinc acetate
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990010479
- gtin03663502000762
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
124 interactions on record for zinc acetate.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Zinc acetate · interactions on record
124 records
- 4 severe
- 31 moderate
- 89 minor
Most severe, free to view
- RaltegravirJ05AJ01severe
- ElvitegravirJ05AJ02severe
- RaltegravirJ05AX08severe
- ElvitegravirJ05AX11severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A16AX05
Zinc acetate, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cbc9f607-7acb-4c52-b064-157e6e039398 GET /v1/drugs/cbc9f607-7acb-4c52-b064-157e6e039398?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki twarde",
"source": "urpl",
"strength": "50 mg",
"packaging": "05909990010479 ¦ Rpz ¦ Skasowane ¦ EU/1/04/286/002 ¦ 24742\n250 kaps.\n03663502000762 ¦ Rpz ¦ EU/1/04/286/002 ¦ 150929\n250 kaps.",
"substance": "Zincum 50 mg",
"common_name": "Zincum",
"pl_product_id": "100129370",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about zinc acetate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.